1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Shionogi & Co., Ltd.
  6. News
  7. All News
    4507   JP3347200002

SHIONOGI & CO., LTD.

(4507)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about SHIONOGI & CO., LTD.
05/24Shionogi Announces Appointment of Corporate Officers, Corporate Reorganization and Pers..
CI
05/24Shionogi Announces appointment of Corporate officers, Corporate Reorganization and Pers..
AQ
05/17Shionogi & Co., Ltd. and F2G Ltd. - Enter Strategic Collaboration to Develop and Commer..
AQ
05/17Shionogi Begins New Clinical Trial for COVID-19 Vaccine, Inks Development and Commercia..
MT
05/16Shionogi & Co., Ltd. - Notice Regarding the Initiation of a Phase 2/3 clinical trial in..
AQ
05/16Shionogi & Co., Ltd. and F2G Ltd., Enter Strategic Collaboration to Develop and Commerc..
CI
05/15Shionogi & Co. Announces Initiation of a Phase 2/3 Clinical Trial in Japanese Adolescen..
CI
05/12Shionogi's Fiscal FY21 Attributable Profit Inches Up Despite 'Aggressive' Investment in..
MT
05/11Shionogi & Co., Ltd. Announces Year-End Dividend for the Year Ended March 31, 2022, Pay..
CI
05/11Shionogi & Co., Ltd. Provides Year-End Dividend Guidance for the Year Ending March 31, ..
CI
05/11Shionogi & Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending ..
CI
05/02FOCUS : Japan Inc. turns to 4-day workweek to offer flexibility to employees
AQ
04/25Shionogi & Co., Ltd. - Notice of Revisions to Earnings and Dividend Forecasts
AQ
04/25New Data for Shionogi's COVID-19 Once-Daily Oral Antiviral S-217622 Show Rapid Virus Cl..
AQ
04/25What you need to know about the coronavirus right now
RE
04/25Japan Index Sees Market-wide Selloff on Weak Global Cues; Renault Weighs Partial Sale o..
MT
04/25SHIONOGI : Notice of Revisions to Earnings and Dividend Forecasts
PU
04/25SHIONOGI : Position and Policy Regarding Reduction of the Investment Unit
PU
04/25Shionogi & Co., Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2022
CI
04/25Shionogi & Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2022
CI
04/24Shionogi Shares Ongoing Findings of COVID-19 Vaccine
MT
04/24Japan's Shionogi says COVID-19 pill shows rapid clearance of virus
RE
04/23SHIONOGI : Presentation Ph2b
PU
04/23SHIONOGI : Presentation Ph1・Ph2a
PU
04/23Shionogi & Co., Ltd. Announces New Results for Oral Antiviral S-217622
CI
04/22Nikkei 225 Declines 1.6% on Federal Reserve Outlook
MT
04/22Japanese shares end lower on weak Wall Street; Toshiba jumps
RE
04/22SHIONOGI : Presents Japanese Phase 2/3 Clinical Trial Results of COVID-19 Recombinant Prot..
PU
04/22Shionogi & Co., Ltd. Presents Japanese Phase 2/3 Clinical Trial Results of COVID-19 Rec..
CI
04/21Japanese shares track Wall Street weakness, tech shares drop
RE
04/21Shionogi shares jump on report U.S. interested in buying COVID pill
RE
04/14Notice Regarding the Media Coverage about S-217622, a Therapeutic Drug for COVID-19
AQ
04/14Nikkei 225 Up 1.2% on Wall Street Cues, Travel Outlook
MT
04/13GLOBAL MARKETS LIVE : LVMH, GSK, Twitter, Blackrock, Walmart...
04/13Shionogi shares plunge on concerns over COVID pill risk to pregnancies
RE
04/13Nikkei 225 Up 1.9% as Yen Strikes 20-Year Low
MT
04/13Shionogi Shares Tank 11% as New COVID-19 Drug Emerges as Risk to Pregnancies
MT
04/13Japan Index Recovers from Losses; Shionogi Shares Tank 11% on COVID-19 Drug Risks
MT
04/13Nikkei sees biggest gain in over 3 weeks after U.S. inflation data
RE
04/12Japanese shares rise on U.S. inflation data; tech stocks lead gains
RE
04/12Shionogi expresses its support for the recommendations of Task Force on Climate-related..
AQ
04/11UK Signs Fixed-Fee Subscription Contracts with Pfizer, Shionogi for New Antibiotic Supp..
MT
04/04Shionogi & Co., Ltd. - Continuation of the Cooperation Agreement with Aichi Prefecture ..
AQ
04/03Japan's Nikkei falls as chip shares track U.S. peers lower
RE
04/01Shionogi & Co., Ltd. - Notice Regarding Completion of Reorganization of Subsidiary thro..
AQ
03/31SHIONOGI : Notice Regarding Completion of Reorganization of Subsidiary through Company Mer..
PU
03/30GlaxoSmithKline Unit Wins US FDA Approval For Pediatric HIV-1 Treatment
MT
03/30SHIONOGI & CO., LTD. : Ex-dividend day for final dividend
FA
03/28Shionogi Inks Government Deal for Supply of COVID-19 Oral Medication
MT
03/28Japan Shares End Nine-Day Streak of Profits; Energy Major Eneos Up 3% on Planned Myanma..
MT
03/25What you need to know about the coronavirus right now
RE
03/25Shionogi & Co., Ltd. - Notice Regarding the Signing of a Basic Agreement with the Minis..
AQ
03/25Nikkei 225 Up 0.1% On Lack of Cues, Dividend Buys
MT
03/25Shionogi Seeks Approval for Manufacturing and Sale of Antibacterial Medicine in Japan
MT
03/25Japan's Nikkei posts longest winning streak in 2-1/2 years
RE
03/24Japan's Shionogi signs govt supply pact for pill to fight COVID
RE
03/24Shionogi & Co., Ltd. Enters into Basic Agreement with the Ministry of Health, Labor and..
CI
03/24Elix, Inc. Begins Collaboration with Shionogi & Co., Ltd. on Elix Synthesize™ (AI ..
CI
03/24GlaxoSmithKline's ViiV Healthcare Secures FDA Nod for Label Update for HIV Treatment In..
MT
03/24Shionogi & Co., Ltd. - Regarding the Filing for Approval of Cefiderocol in Japan
AQ
03/24SHIONOGI : Regarding the Filing for Approval of Cefiderocol in Japan
PU
03/24Shionogi & Co., Ltd. Announces Regarding the Filing for Approval of Cefiderocol in Japa..
CI
03/22Shanghai Pharma Denies Working With Japan's Shionogi on COVID-19 Drug; Shanghai Shares ..
MT
03/17ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 Oral Anti..
AQ
03/17Shionogi Gets FDA Nod on Investigational New Drug Application for Oral COVID-19 Medicin..
MT
03/16SHIONOGI : ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 O..
PU
03/16ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 Oral Anti..
CI
03/15New purchases in the MarketScreener Asia Portfolio
03/14Shionogi provides humanitarian aid to Ukraine
AQ
03/11Japan's Fujifilm to halt enrollment in Avigan trial for COVID-19
RE
03/10Japan considers offering fourth COVID vaccine shot - Yomiuri
RE
03/07Shionogi Releases Interim Report on COVID-19 Vaccine Trial
MT
03/04Shionogi Presents the Interim Report (Top-line Results) of a Phase 2/3 Additional Dose ..
AQ
03/04SHIONOGI : Presents the Interim Report (Top-line Results) of a Phase 2/3 Additional Dose C..
PU
03/04SHIONOGI : Top-Line Results of the Phase 2/3 booster Trial for COVID-19 Recombinant-based ..
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SHIONOGI & CO., LTD.